PG
Procter & Gamble Company
Procter & Gamble Company historical holders
total: 18
Trian Fund Management Procter & Gamble Company transactions over time
- Total transactions:
- 20
- New positions:
- 1
- Sold out:
- 1
- Added:
- 6
- Reduced:
- 12
- Held since:
- 2016 Q4
- Held for:
- 24 quarters
- Latest activity:
- 2022 Q4
Nelson Peltz has been an institutional investor in Procter & Gamble Company (PG) since 2016 Q4. According to 2026 Q1 report, Nelson Peltz doesn't hold any shares. The fund/company first acquired PG in 2016 Q4, initially purchasing about 6.42M shares. Since the initial investment, Trian Fund Management has made 19 more transactions in this position.
When did Nelson Peltz exit their PG position?
Nelson Peltz no longer holds Procter & Gamble Company (PG). They sold off their entire position in 2022 Q4, closing out an investment that began in 2016 Q4.
When did Nelson Peltz first invest in PG?
Nelson Peltz first invested in Procter & Gamble Company (PG) in 2016 Q4 at the reported quarter-end price of $84.08 per share, acquiring 6,416,284 shares in their initial purchase.
What is Nelson Peltz's average cost basis for PG?
Based on historical transaction data, Nelson Peltz's estimated cost basis for Procter & Gamble Company (PG) is approximately $88.82 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $88.82
- Weighted AVG sell price:
- $127.95
PG transactions history by Trian Fund Management
20 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$126.32
|
|
-100% (-5,589)
|
-0.02%
|
|
2022 Q3
|
0.02%
|
5,589
|
$126.32
|
$706,000
|
+2.42% (+132)
|
+0%
|
|
2022 Q1
|
0.01%
|
5,457
|
$163.64
|
$893,000
|
-97.70% (-231,927)
|
-0.51%
|
|
2021 Q4
|
0.52%
|
237,384
|
$163.58
|
$38,831,000
|
-95.50% (-5,032,139)
|
-10.23%
|
|
2021 Q3
|
9.16%
|
5,269,523
|
$139.80
|
$736,679,000
|
-9.02% (-522,262)
|
-0.85%
|
|
2021 Q2
|
9.14%
|
5,791,785
|
$134.93
|
$781,486,000
|
-34.81% (-3,093,092)
|
-4.94%
|
|
2021 Q1
|
14.23%
|
8,884,877
|
$135.43
|
$1,203,279,000
|
-9.56% (-938,847)
|
-1.88%
|
|
2020 Q4
|
20.23%
|
$139.14
|
-3.01% (-305,151)
|
|||
|
2020 Q3
|
23.26%
|
$138.99
|
-6.44% (-696,977)
|
|||
|
2020 Q2
|
23.41%
|
$119.57
|
-65.12% (-20,208,933)
|
|||
|
2020 Q1
|
49.20%
|
$110.00
|
-3.48% (-1,119,842)
|
|||
|
2019 Q4
|
42.34%
|
$124.90
|
-12.22% (-4,475,930)
|
|||
|
2019 Q3
|
47.56%
|
$124.38
|
+0.00% (+14)
|
|||
|
2019 Q2
|
42.39%
|
$109.65
|
-0.19% (-71,485)
|
|||
|
2019 Q1
|
40.87%
|
$104.05
|
-3.19% (-1,208,738)
|
|||
|
2018 Q4
|
37.73%
|
$91.92
|
+0.01% (+2,145)
|
|||
|
2017 Q3
|
26.56%
|
$90.98
|
+0.79% (+296,609)
|
|||
|
2017 Q2
|
24.71%
|
$87.15
|
+2.43% (+893,157)
|
|||
|
2017 Q1
|
24.74%
|
$89.85
|
+472.28% (+30,302,571)
|
|||
|
2016 Q4
|
4.86%
|
$84.08
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.